SARS-CoV-2 infection after COVID-19 vaccinations among vaccinated individuals, prevention rate of COVID-19 vaccination: A systematic review and meta-analysis

被引:1
|
作者
Dinagde, Dagne Deresa [1 ]
Degefa, Bekam Dibaba [1 ]
Kitil, Gemeda Wakgari [1 ]
Feyisa, Gizu Tola [1 ]
Marami, Shambel Negese [1 ]
机构
[1] Mattu Univ, Coll Hlth Sci, Dept Midwifery, Mettu, Ethiopia
关键词
SARS; COVID reinfection; Meta; -analysis; COVID-19; vaccination; Post COVID-19;
D O I
10.1016/j.heliyon.2024.e30609
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The global concern regarding protection against the COVID-19 variants through preexisting antibodies from vaccination or previous infection is evident. Reports from around the world indicate that a considerable number of healthcare professionals/individuals experience reinfection despite being vaccinated. Moreover, several studies have highlighted cases of symptomatic SARS-CoV-2 re -infection, specifically among individuals who have been vaccinated. Understanding the factors that contribute to these re -infections is crucial for implementing effective public health measures and enhancing vaccination strategies. Method: A comprehensive search was conducted between January 1, 2021, and February 14, 2024, using various reputable sources such as PubMed, Google scholar, Medline, EMBASE, CINAHL, and others. The search aimed to retrieve relevant research on topics related to "world nations" and phrases like "COVID-19 vaccination breakthrough infection," "SARS re -infection after COVID-19 vaccination," "COVID-19 vaccine complication," "post COVID-19 vaccination symptoms," and specific nation names. The data obtained from the databases underwent extraction and quality assessment using the Newcastle -Ottawa Scale (NOS) and the Preferred Reporting Items for Systematic Review and Meta -Analyses. Data analysis was performed using STATA 17 MP software, and measures such as the I 2 test statistic and Egger's test were used to assess heterogeneity and publication bias. The findings were presented using forest plots, displaying the odds ratio (OR) and 95 % confidence interval (CI). Result: This review and meta -analysis comprised a total of 15 articles, or a total sample size of 342,598. The pooled prevalence of SARS-CoV-2 after vaccination of COVID-19 was 9 % (95CI 7%-11 %) of population globally. This implied that reduced the overall attack rate of COVID-19 by 91 % after vaccination. The highest pooled estimated of SARS-CoV-2 infection after COVID -19 Vaccinations was seen among developing nations, 20 % (95 % CI: 5%-36 %).The pooled odds ratio showed that a significant association was found between SARS-CoV-2 infection after COVID19 vaccination and older age (OR = 2.04; 95%CI: 1.10-2.98) and comorbidity (OR = 3.25; 95% CI: 1.04-5.47). Conclusion: It is important for policymakers to prioritize continuous monitoring and surveillance of SARS-CoV-2 infection rates among vaccinated individuals globally, as there is a significant estimate of the combined prevalence of post-COVID-19 vaccine SARS-CoV-2 infections.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
    Ceban, Felicia
    Kulzhabayeva, Dana
    Rodrigues, Nelson B.
    Di Vincenzo, Joshua D.
    Gill, Hartej
    Subramaniapillai, Mehala
    Lui, Leanna M. W.
    Cao, Bing
    Mansur, Rodrigo B.
    Ho, Roger C.
    Burke, Matthew J.
    Rhee, Taeho Greg
    Rosenblat, Joshua D.
    McIntyre, Roger S.
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 111 : 211 - 229
  • [22] SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with Inflammatory Bowel Disease: A systematic review and meta-analysis
    Van De Pol, N.
    Pan, Q.
    Derikx, L. A. A. P.
    Bakker, L.
    van der Woude, C. J.
    de Vries, A. C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 960 - 960
  • [23] SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
    van de Pol, Natasja
    Pan, Qiuwei
    Derikx, Lauranne A. A. P.
    Bakker, Linda
    van der Woude, C. Janneke
    de Vries, Annemarie C.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [24] SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
    van de Pol, Natasja
    Pan, Qiuwei
    Derikx, Lauranne A. A. P.
    Bakker, Linda
    van der Woude, C. Janneke
    de Vries, Annemarie C.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [25] SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
    Paddy Ssentongo
    Anna E. Ssentongo
    Navya Voleti
    Destin Groff
    Ashley Sun
    Djibril M. Ba
    Jonathan Nunez
    Leslie J. Parent
    Vernon M. Chinchilli
    Catharine I. Paules
    BMC Infectious Diseases, 22
  • [26] Use of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: a systematic review and meta-analysis
    Tanni, Suzana E.
    Bacha, Helio A.
    Naime, Alexandre
    Bernardo, Wanderley M.
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (05)
  • [27] Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis
    Kazemi, Asma
    Mohammadi, Vida
    Aghababaee, Sahar Keshtkar
    Golzarand, Mahdieh
    Clark, Cain C. T.
    Babajafari, Siavash
    ADVANCES IN NUTRITION, 2021, 12 (05) : 1636 - 1658
  • [28] SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
    Ssentongo, Paddy
    Ssentongo, Anna E.
    Voleti, Navya
    Groff, Destin
    Sun, Ashley
    Ba, Djibril M.
    Nunez, Jonathan
    Parent, Leslie J.
    Chinchilli, Vernon M.
    Paules, Catharine, I
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [29] Accuracy of SARS-CoV-2 Detection in Saliva for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis
    Elkady, Dina M.
    Abdella, Walid Shaban
    Abdella, Muhamed
    Kopeya, Abdelrahman Elsayed
    Hamdallah, Aboalmagd
    FRONTIERS IN EMERGENCY MEDICINE, 2021, 5 (04):
  • [30] Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis
    Singh, Surjit
    Khera, Daisy
    Chugh, Ankita
    Khera, Pushpinder Singh
    Chugh, Vinay Kumar
    BMJ OPEN, 2021, 11 (06):